chr1-32362003-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001167676.2(FAM229A):c.89C>A(p.Ala30Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000375 in 1,333,252 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001167676.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM229A | NM_001167676.2 | c.89C>A | p.Ala30Asp | missense_variant | 1/3 | ENST00000432622.2 | NP_001161148.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM229A | ENST00000432622.2 | c.89C>A | p.Ala30Asp | missense_variant | 1/3 | 2 | NM_001167676.2 | ENSP00000455971.1 | ||
FAM229A | ENST00000416512.1 | n.2221C>A | non_coding_transcript_exon_variant | 1/2 | 1 | |||||
TSSK3 | ENST00000574315.1 | c.-80-1592G>T | intron_variant | 3 | ENSP00000459187.1 | |||||
FAM229A | ENST00000415596.1 | n.253C>A | non_coding_transcript_exon_variant | 2/3 | 3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000238 AC: 2AN: 83876Hom.: 0 AF XY: 0.0000419 AC XY: 2AN XY: 47680
GnomAD4 exome AF: 0.00000375 AC: 5AN: 1333252Hom.: 0 Cov.: 32 AF XY: 0.00000457 AC XY: 3AN XY: 657002
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 18, 2024 | The c.89C>A (p.A30D) alteration is located in exon 1 (coding exon 1) of the FAM229A gene. This alteration results from a C to A substitution at nucleotide position 89, causing the alanine (A) at amino acid position 30 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at